Fundz
Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Cyclacel Pharmaceuticals Closes Warrant Exercise, Raises $2.1 Million

Nov 14, 2024•over 1 year ago

Contract Type

contract

Berkeley HeightsBiotechnologyTherapeuticsPharmaceuticalBiopharma

Description

Cyclacel Pharmaceuticals, Inc. announced the closing of the exercise of certain existing warrants, resulting in gross proceeds of approximately $2.1 million. In consideration for the exercise of the existing warrants for cash, the Company issued new unregistered Series C and Series D warrants to purchase shares of common stock.

Company Information

Company

Cyclacel Pharmaceuticals

Location

200 CONNELL DRIVE, SUITE 1500

Berkeley Heights, New Jersey, United States

About

Cyclacel Pharmaceuticals, Inc. is a biopharmaceutical company developing innovative cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis biology. The Company's strategy is to build a diversified biopharmaceutical business based on a pipeline of novel drug candidates addressing oncology and hematology indications.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Cyclacel Pharmaceuticals's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.